1. Home
  2. RR vs IMMX Comparison

RR vs IMMX Comparison

Compare RR & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Richtech Robotics Inc. Class B

RR

Richtech Robotics Inc. Class B

HOLD

Current Price

$1.57

Market Cap

614.9M

Sector

N/A

ML Signal

HOLD

Logo Immix Biopharma Inc.

IMMX

Immix Biopharma Inc.

HOLD

Current Price

$8.60

Market Cap

716.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RR
IMMX
Founded
2016
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
614.9M
716.2M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
RR
IMMX
Price
$1.57
$8.60
Analyst Decision
Hold
Strong Buy
Analyst Count
2
5
Target Price
$4.00
$19.20
AVG Volume (30 Days)
7.5M
2.1M
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,045,000.00
N/A
Revenue This Year
$75.68
N/A
Revenue Next Year
$78.28
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.99
N/A
52 Week Low
$1.53
$1.94
52 Week High
$7.43
$12.14

Technical Indicators

Market Signals
Indicator
RR
IMMX
Relative Strength Index (RSI) 31.99 39.80
Support Level $1.53 $7.99
Resistance Level $2.21 $9.37
Average True Range (ATR) 0.09 0.90
MACD 0.01 -0.28
Stochastic Oscillator 4.63 1.93

Price Performance

Historical Comparison
RR
IMMX

About RR Richtech Robotics Inc. Class B

Richtech Robotics Inc is a robotics and artificial intelligence (AI) technology company focused on developing embodied AI systems that aims to improve the efficiency and productivity of businesses. The company trains proprietary artificial intelligence models on in-house data to operate robotic systems in the real world. It designs, engineers, manufactures, and deploys next generation embodied AI systems to serve a wide range of industries, including food service, retail, industrial manufacturing, automotive, healthcare, and hospitality. The company's offerings include Commercial Robotic Products, Industrial Robotic Products and Data Services. The company generated the majority of its revenue through product revenue (i.e. outright hardware sales).

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

Share on Social Networks: